- Home
- CVM vs WLGS Comparison
CVM vs WLGS Comparison
Compare CVM & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- WLGS
- Stock Information
- Founded
- CVM 1983
- WLGS 1981
- Country
- CVM United States
- WLGS Hong Kong
- Employees
- CVM N/A
- WLGS N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- WLGS Engineering & Construction
- Sector
- CVM Health Care
- WLGS Consumer Discretionary
- Exchange
- CVM Nasdaq
- WLGS Nasdaq
- Market Cap
- CVM 40.1M
- WLGS 41.7M
- IPO Year
- CVM 1987
- WLGS 2023
- Fundamental
- Price
- CVM $0.62
- WLGS $2.21
- Analyst Decision
- CVM
- WLGS
- Analyst Count
- CVM 0
- WLGS 0
- Target Price
- CVM N/A
- WLGS N/A
- AVG Volume (30 Days)
- CVM 469.2K
- WLGS 129.1K
- Earning Date
- CVM 02-12-2025
- WLGS 12-31-2024
- Dividend Yield
- CVM N/A
- WLGS N/A
- EPS Growth
- CVM N/A
- WLGS N/A
- EPS
- CVM N/A
- WLGS N/A
- Revenue
- CVM N/A
- WLGS $6,825,879.00
- Revenue This Year
- CVM N/A
- WLGS N/A
- Revenue Next Year
- CVM $3,412.81
- WLGS N/A
- P/E Ratio
- CVM N/A
- WLGS N/A
- Revenue Growth
- CVM N/A
- WLGS 63.69
- 52 Week Low
- CVM $0.49
- WLGS $0.44
- 52 Week High
- CVM $3.23
- WLGS $5.57
- Technical
- Relative Strength Index (RSI)
- CVM 45.83
- WLGS 38.98
- Support Level
- CVM $0.60
- WLGS $2.31
- Resistance Level
- CVM $0.78
- WLGS $3.19
- Average True Range (ATR)
- CVM 0.09
- WLGS 0.65
- MACD
- CVM 0.02
- WLGS -0.23
- Stochastic Oscillator
- CVM 45.66
- WLGS 2.96
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.